We hereby proved that intranasal IL-13 treatment neither changed the infiltration of peripheral immune cells, which enters the brain to participate in central immunity after a stroke, nor did it change the immune cell population in blood, spleen and lung. This evidence concerns the gene IL13 and Stroke.